Atypical parkinsonian syndromes

a general neurologist's perspective

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The differential diagnosis of atypical parkinsonian syndromes is challenging. These severe and often rapidly progressive neurodegenerative disorders are clinically heterogeneous and show significant phenotypic overlap. Here, clinical, imaging, neuropathological and genetic features of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and frontotemporal lobar degeneration (FTLD) are reviewed. The terms corticobasal degeneration and FTLD refer to pathologically confirmed cases of corticobasal syndrome and frontotemporal dementia (FTD). Frontotemporal lobar degeneration clinically presents as the behavioral variant FTD, semantic variant primary progressive aphasia (PPA), non-fluent agrammatic variant PPA, logopenic variant PPA and FTD associated with motor neuron disease. While progressive supranuclear palsy and corticobasal syndrome have been called Parkinson-plus syndromes in the past, they are now classified as FTD-related disorders, reflecting that they pathologically differ from α-synucleinopathies like multiple system atrophy and Parkinson disease. The contribution of genetic factors to atypical parkinsonian syndromes is increasingly recognized. Genes involved in the etiology of FTLD include MAPT, GRN and C9orf72. Novel neuroimaging techniques, including tau positron emission tomography imaging, are being investigated. Multimodal magnetic resonance imaging approaches and automated magnetic resonance imaging volume segmentation techniques are being evaluated for optimized differential diagnosis. Current treatment options are symptomatic, and disease modifying therapies are under active investigation.

Original languageEnglish (US)
Pages (from-to)41-58
Number of pages18
JournalEuropean Journal of Neurology
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Frontotemporal Lobar Degeneration
Parkinsonian Disorders
Frontotemporal Dementia
Primary Progressive Aphasia
Progressive Supranuclear Palsy
Multiple System Atrophy
Primary Progressive Nonfluent Aphasia
Differential Diagnosis
Magnetic Resonance Imaging
Semantics
Neuroimaging
Neurodegenerative Diseases
Positron-Emission Tomography
Parkinson Disease
Neurologists
Therapeutics
Genes

Keywords

  • corticobasal syndrome
  • frontotemporal dementia
  • multiple system atrophy
  • primary progressive aphasia
  • progressive supranuclear palsy
  • tauopathy
  • α-synucleinopathy

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Atypical parkinsonian syndromes : a general neurologist's perspective. / Deutschländer, A. B.; Ross, Owen A; Dickson, Dennis W; Wszolek, Zbigniew K.

In: European Journal of Neurology, Vol. 25, No. 1, 01.01.2018, p. 41-58.

Research output: Contribution to journalReview article

@article{2ae93338ebff4ede95b256cc60279773,
title = "Atypical parkinsonian syndromes: a general neurologist's perspective",
abstract = "The differential diagnosis of atypical parkinsonian syndromes is challenging. These severe and often rapidly progressive neurodegenerative disorders are clinically heterogeneous and show significant phenotypic overlap. Here, clinical, imaging, neuropathological and genetic features of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and frontotemporal lobar degeneration (FTLD) are reviewed. The terms corticobasal degeneration and FTLD refer to pathologically confirmed cases of corticobasal syndrome and frontotemporal dementia (FTD). Frontotemporal lobar degeneration clinically presents as the behavioral variant FTD, semantic variant primary progressive aphasia (PPA), non-fluent agrammatic variant PPA, logopenic variant PPA and FTD associated with motor neuron disease. While progressive supranuclear palsy and corticobasal syndrome have been called Parkinson-plus syndromes in the past, they are now classified as FTD-related disorders, reflecting that they pathologically differ from α-synucleinopathies like multiple system atrophy and Parkinson disease. The contribution of genetic factors to atypical parkinsonian syndromes is increasingly recognized. Genes involved in the etiology of FTLD include MAPT, GRN and C9orf72. Novel neuroimaging techniques, including tau positron emission tomography imaging, are being investigated. Multimodal magnetic resonance imaging approaches and automated magnetic resonance imaging volume segmentation techniques are being evaluated for optimized differential diagnosis. Current treatment options are symptomatic, and disease modifying therapies are under active investigation.",
keywords = "corticobasal syndrome, frontotemporal dementia, multiple system atrophy, primary progressive aphasia, progressive supranuclear palsy, tauopathy, α-synucleinopathy",
author = "Deutschl{\"a}nder, {A. B.} and Ross, {Owen A} and Dickson, {Dennis W} and Wszolek, {Zbigniew K}",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ene.13412",
language = "English (US)",
volume = "25",
pages = "41--58",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Atypical parkinsonian syndromes

T2 - a general neurologist's perspective

AU - Deutschländer, A. B.

AU - Ross, Owen A

AU - Dickson, Dennis W

AU - Wszolek, Zbigniew K

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The differential diagnosis of atypical parkinsonian syndromes is challenging. These severe and often rapidly progressive neurodegenerative disorders are clinically heterogeneous and show significant phenotypic overlap. Here, clinical, imaging, neuropathological and genetic features of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and frontotemporal lobar degeneration (FTLD) are reviewed. The terms corticobasal degeneration and FTLD refer to pathologically confirmed cases of corticobasal syndrome and frontotemporal dementia (FTD). Frontotemporal lobar degeneration clinically presents as the behavioral variant FTD, semantic variant primary progressive aphasia (PPA), non-fluent agrammatic variant PPA, logopenic variant PPA and FTD associated with motor neuron disease. While progressive supranuclear palsy and corticobasal syndrome have been called Parkinson-plus syndromes in the past, they are now classified as FTD-related disorders, reflecting that they pathologically differ from α-synucleinopathies like multiple system atrophy and Parkinson disease. The contribution of genetic factors to atypical parkinsonian syndromes is increasingly recognized. Genes involved in the etiology of FTLD include MAPT, GRN and C9orf72. Novel neuroimaging techniques, including tau positron emission tomography imaging, are being investigated. Multimodal magnetic resonance imaging approaches and automated magnetic resonance imaging volume segmentation techniques are being evaluated for optimized differential diagnosis. Current treatment options are symptomatic, and disease modifying therapies are under active investigation.

AB - The differential diagnosis of atypical parkinsonian syndromes is challenging. These severe and often rapidly progressive neurodegenerative disorders are clinically heterogeneous and show significant phenotypic overlap. Here, clinical, imaging, neuropathological and genetic features of multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration and frontotemporal lobar degeneration (FTLD) are reviewed. The terms corticobasal degeneration and FTLD refer to pathologically confirmed cases of corticobasal syndrome and frontotemporal dementia (FTD). Frontotemporal lobar degeneration clinically presents as the behavioral variant FTD, semantic variant primary progressive aphasia (PPA), non-fluent agrammatic variant PPA, logopenic variant PPA and FTD associated with motor neuron disease. While progressive supranuclear palsy and corticobasal syndrome have been called Parkinson-plus syndromes in the past, they are now classified as FTD-related disorders, reflecting that they pathologically differ from α-synucleinopathies like multiple system atrophy and Parkinson disease. The contribution of genetic factors to atypical parkinsonian syndromes is increasingly recognized. Genes involved in the etiology of FTLD include MAPT, GRN and C9orf72. Novel neuroimaging techniques, including tau positron emission tomography imaging, are being investigated. Multimodal magnetic resonance imaging approaches and automated magnetic resonance imaging volume segmentation techniques are being evaluated for optimized differential diagnosis. Current treatment options are symptomatic, and disease modifying therapies are under active investigation.

KW - corticobasal syndrome

KW - frontotemporal dementia

KW - multiple system atrophy

KW - primary progressive aphasia

KW - progressive supranuclear palsy

KW - tauopathy

KW - α-synucleinopathy

UR - http://www.scopus.com/inward/record.url?scp=85038896130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038896130&partnerID=8YFLogxK

U2 - 10.1111/ene.13412

DO - 10.1111/ene.13412

M3 - Review article

VL - 25

SP - 41

EP - 58

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -